Active surveillance of prostate cancer leads to improved quality of life
the ONA take:
Prostate cancer is usually a slow-growing cancer. As a result, many men can opt to delay or avoid undergoing treatment. The process, referred to as active surveillance, allows men with prostate cancer to delay or avoid the side effects of its treatment as well.
Although the side effects of prostate cancer treatment can affect quality of life, the impact active surveillance has on quality of life is questionable. In this study, researchers found 10 previous studies that examined quality of life and other psychological issues related to men coping with prostate cancer.
The studies included 966 men with prostate cancer, all of whom chose active surveillance over aggressive treatment.
The results of this review show that quality of life scores for men who chose active surveillance were similar to the scores for men who chose surgery. Anxiety, depression, and general distress scores also were not worse in the active surveillance group.
The researchers conclude that although men who opt for active surveillance do not experience worse quality of life, they should still be assessed for potential problems and offered support as needed.
Active surveillance allows men with prostate cancer to delay or avoid the side effects of its treatment as well.
Additionally, the men who decided to track their cancers in a process known as "active surveillance" did not appear to suffer added emotional stress, researchers found. "The men in our study did not appear to suffer from any major negative psychological impacts, including anxiety and depression," said Dr. Lara Bellardita, the study's lead author from the IRCCS Foundation's National Cancer Institute in Milan, Italy.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- High Symptom Burden With Polycythemia Vera Linked to QoL Impairment
- Bioimpedence Spectroscopy Improves Early Detection of Breast Cancer-Related Lymphedema in At-Risk Patients
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- Ruxolitinib: A Targeted Treatment Option for Patients with Polycythemia Vera
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Study Assesses Efficacy of Ramucirumab in HCC by Child-Pugh Score
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Patient Navigation Reduces Delays in Diagnostic Resolution
- Fee-for-service Medicare Plans Linked to Improved Care During Last Year of Life
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|